| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6124788 | Osteoarthritis and Cartilage | 2014 | 8 Pages |
Abstract
IAHA for the treatment of KBD was safe and efficacious at 12 months with low and transient adverse reactions. However, more high-quality randomized controlled trials (RCTs) are needed to confirm its therapeutic effect.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
F.F. Yu, C.T. Xia, H. Fang, J. Han, M.I. Younus, X. Guo,